Laser nanobubbles induce immunogenic cell death in breast cancer

Nanoscale. 2021 Feb 14;13(6):3644-3653. doi: 10.1039/d0nr06587k. Epub 2021 Feb 4.

Abstract

Recent advances in immunotherapy have highlighted a need for therapeutics that initiate immunogenic cell death in tumors to stimulate the body's immune response to cancer. This study examines whether laser-generated bubbles surrounding nanoparticles ("nanobubbles") induce an immunogenic response for cancer treatment. A single nanosecond laser pulse at 1064 nm generates micron-sized bubbles surrounding gold nanorods in the cytoplasm of breast cancer cells. Cell death occurred in cells treated with nanorods and irradiated, but not in cells with irradiation treatment alone. Cells treated with nanorods and irradiation had increased damage-associated molecular patterns (DAMPs), including increased expression of chaperone proteins human high mobility group box 1 (HMGB1), adenosine triphosphate (ATP), and heat shock protein 70 (HSP70). This enhanced expression of DAMPs led to the activation of dendritic cells. Overall, this treatment approach is a rapid and highly specific method to eradicate tumor cells with simultaneous immunogenic cell death signaling, showing potential as a combination strategy for immunotherapy.

MeSH terms

  • Breast Neoplasms* / therapy
  • Calreticulin / metabolism
  • HMGB1 Protein*
  • Humans
  • Immunogenic Cell Death
  • Lasers

Substances

  • Calreticulin
  • HMGB1 Protein